A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Clinical trial NCT02531373 · COMPLETED
Trial details
- NCT number
- NCT02531373
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-15
- Primary completion
- 2017-04-14
- Enrollment
- 338
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.